PSS27 USING MEDICATION POSSESSION AND DAYS OF COVERAGE ON THERAPYTO ASSESS PERSISTENCE WITH PROSTAGLANDIN OCULAR HYPOTENSIVE THERAPY
S Kotak, GF Schwartz, G Reardon, SN ShahVolume:
11
Year:
2008
Language:
english
DOI:
10.1016/s1098-3015(10)70922-0
File:
PDF, 93 KB
english, 2008